Literature DB >> 17251802

Lacrimal punctum occlusion in the treatment of severe keratoconjunctivitis Sicca caused by Sjögren syndrome: a uniocular evaluation.

Khaled Mansour1, Carolien J Leonhardt, Wouter W Kalk, Hendrika Bootsma, Klaas J Bruin, Lieuwe J Blanksma.   

Abstract

PURPOSE: A controlled uniocular study to evaluate the short-term efficacy of lacrimal punctum occlusion in the treatment of severe dry eye caused by Sjögren syndrome.
METHODS: Uniocular punctum occlusion by punctum plug in the upper and lower puncta in 1 eye was performed in 20 patients with severe keratoconjunctivitis Sicca caused by Sjögren syndrome. To overcome possible interindividual variability between patients, the other eye, in the same patient, was not occluded and served as a control eye. The eye to be occluded was randomly selected. The patients were instructed to continue using their dry eye medications. Tear function tests (Schirmer test, rose Bengal test, and debris in de cul-de-sac) were performed in both eyes. Subjective complaints (discomfort) were registered for both eyes. All the above-mentioned data were collected before starting the treatment and at least 6 weeks later. The above-mentioned parameters were compared and statistically analyzed in both eyes.
RESULTS: Of the 20 patients, 7 patients dropped out. The remaining 13 patients completed the final analysis. In the occluded eye, we found a significant improvement in both the subjective complaints and the rose Bengal score, but the Schirmer test and the tear mucus score did not change.
CONCLUSION: Punctum occlusion therapy in a short-term study improved the rose Bengal score and discomfort score in our patients and thus may be helpful in the treatment of severe dry eye caused by Sjögren syndrome.

Entities:  

Mesh:

Year:  2007        PMID: 17251802     DOI: 10.1097/01.ico.0000244877.30997.6a

Source DB:  PubMed          Journal:  Cornea        ISSN: 0277-3740            Impact factor:   2.651


  9 in total

1.  Clinical efficacy of the SmartPlug™ in the treatment of primary Sjogren's syndrome with keratoconjunctivitis sicca: one-year follow-up study.

Authors:  Sait Egrilmez; Fatih Aslan; Gonca Karabulut; Yasemin Kabasakal; Ayse Yagci
Journal:  Rheumatol Int       Date:  2010-05-21       Impact factor: 2.631

Review 2.  Punctal occlusion for dry eye syndrome.

Authors:  Ann-Margret Ervin; Robert Wojciechowski; Oliver Schein
Journal:  Cochrane Database Syst Rev       Date:  2010-09-08

Review 3.  Punctal occlusion for dry eye syndrome.

Authors:  Ann-Margret Ervin; Andrew Law; Andrew D Pucker
Journal:  Cochrane Database Syst Rev       Date:  2017-06-26

4.  Efficacy and retention of silicone punctal plugs for treatment of dry eye in patients with and without ocular graft-versus-host-disease.

Authors:  Rohan Bir Singh; Ann Yung; Giulia Coco; Shruti Sinha; Thomas H Dohlman; Jia Yin; Reza Dana
Journal:  Ocul Surf       Date:  2020-07-30       Impact factor: 5.033

Review 5.  [Typical questions from the rheumatologist to the ophthalmologist and cooperating radiologist].

Authors:  B Nölle; M Both; M Heller; J B Roider
Journal:  Z Rheumatol       Date:  2008-09       Impact factor: 1.372

Review 6.  [Mucous membrane pemphigoid with ocular involvement. Part II: therapy].

Authors:  T Meyer-ter-Vehn; E Schmidt; D Zillikens; G Geerling
Journal:  Ophthalmologe       Date:  2008-04       Impact factor: 1.059

Review 7.  A systematic review of non-pharmacological interventions for primary Sjögren's syndrome.

Authors:  Katie L Hackett; Katherine H O Deane; Victoria Strassheim; Vincent Deary; Tim Rapley; Julia L Newton; Wan-Fai Ng
Journal:  Rheumatology (Oxford)       Date:  2015-06-30       Impact factor: 7.580

Review 8.  Systematic review of randomized controlled trials in the treatment of dry eye disease in Sjogren syndrome.

Authors:  Kendrick Co Shih; Christie Nicole Lun; Vishal Jhanji; Bernard Yu-Hor Thong; Louis Tong
Journal:  J Inflamm (Lond)       Date:  2017-11-21       Impact factor: 4.981

9.  Improving eye-drop administration skills of patients - A multicenter parallel-group cluster-randomized controlled trial.

Authors:  Anette Lampert; Thomas Bruckner; Walter E Haefeli; Hanna M Seidling
Journal:  PLoS One       Date:  2019-02-21       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.